Botox’s biggest rival lands in the US — Leytbo said to be faster-acting and up to 30% cheaper
There’s a new age-defying treatment coming to a dermatology office near you. Rivaling widely popular anti-aging injectables like Botox and Daxxify, the recently FDA-approved neuromodulator Letybo has arrived State-side after years of use overseas. The Hugel-manufactured Letybo has soared in popularity in South Korea, where providers “have used it zillions of times,” Dr. Roy Kim, … Read more